Doxycycline is a tetracycline antibiotic commonly prescribed for moderate to severe rosacea. Brand names include Vibramycin, ...

Patients with rosacea experienced improvement with Emrosi, an oral minocycline hydrochloride extended-release product, ...

The trials, published in the Journal of the American Medical Association - Dermatology, showed that Emrosi™ met all primary and secondary endpoints, demonstrating statistical superiority over both ...

Rosacea is estimated to affect around 16 ... is the first new oral treatment for the condition since Galderma's Oracea (doxycycline) was launched in 2006. Maraoui said Emrosi offers a "unique ...

In the Minocycline Versus Oracea® in Rosacea-1 (MVOR-1) and Minocycline Versus Oracea in Rosacea-2 (MVOR-2) trials, subjects were randomized to receive DFD-29, Oracea, or placebo. The co-primary ...